Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Excipients > Croscarmellose Sodium CAS 74811-65-7

Croscarmellose Sodium CAS 74811-65-7

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 74811-65-7

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
74811-65-7
Appearance::
White To Grayish White Powder
Molecular Formula::
C8H9NaO7
Molecular Weight::
241.15100
EINECS NO::
NA
MDL NO::
MFCD00217760
CAS NO::
74811-65-7
Appearance::
White To Grayish White Powder
Molecular Formula::
C8H9NaO7
Molecular Weight::
241.15100
EINECS NO::
NA
MDL NO::
MFCD00217760
Croscarmellose Sodium CAS 74811-65-7

Product Description:

Product Name: Croscarmellose Sodium CAS NO: 74811-65-7

 

Synonyms:

Croscarmellose natrium;

Croscarmellose sodium;

Cross-linked carboxymethylcellulose sodium;

 

Chemical & Physical Properties:

Appearance: white to grayish white powder

Assay :≥99.0%

Density: Bulk density (g/cc) 0.48

Solubility: Practically insoluble in ace-tone, in anhydrous ethanol and in toluene.

 

Croscarmellose natrium is used as Disintegrant in Capsules, Tablet and Granule Formulations. Croscarmellose sodium is used in oral pharmaceutical formulations as a disintegrant for capsules,tablets, and granules.

In tablet formulations, croscarmellose sodium may be used in bothdirect-compressionandwet-granulationprocesses.Whenused in wet granulations, the croscarmellose sodium should be added in both the wet and dry stages of the process (intra- and extragranularly) so that the wicking and swelling ability of the disintegrant is best utilized. Croscarmellose sodium at concentrations up to 5% w/w may be used as a tablet disintegrant, although normally 2% w/w is used in tablets prepared by direct compression and 3% w/w in tablets prepared by a wet-granulation process.

 

If you are interested in our products or have any questions, please feel free to contact us!

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.